Michel Pierre Rose Berthelin
Known title: EVP, EMEACIK: 0001770498
Associated companies
Transaction History
| ADNT | ▼ Sell | Open Market | 2,500 | $49K | 11/26/2025 | View on chart |
| ADNT | ▼ Sell | Tax Withholding | 2,235 | $43K | 11/17/2025 | View on chart |
| ADNT | ▼ Sell | Tax Withholding | 3,056 | $61K | 11/16/2025 | View on chart |
| ADNT | ▼ Sell | Tax Withholding | 5,459 | $109K | 11/14/2025 | View on chart |
| ADNT | ▲ Buy | Grant | 4,685 | — | 11/13/2025 | View on chart |
| ADNT | ▼ Sell | Tax Withholding | 1,672 | $33K | 11/18/2024 | View on chart |
| ADNT | ▼ Sell | Tax Withholding | 2,169 | $43K | 11/17/2024 | View on chart |
| ADNT | ▼ Sell | Tax Withholding | 3,056 | $61K | 11/16/2024 | View on chart |
| ADNT | ▲ Buy | Grant | 8,385 | — | 11/14/2024 | View on chart |
| ADNT | ▼ Sell | Tax Withholding | 3,983 | $81K | 11/14/2024 | View on chart |
| ADNT | ▲ Buy | Grant | 34,823 | — | 11/14/2024 | View on chart |
| ADNT | ▼ Sell | Open Market | 1,300 | $44K | 2/20/2024 | View on chart |
| ADNT | ▼ Sell | Tax Withholding | 2,518 | $83K | 11/19/2023 | View on chart |
| ADNT | ▼ Sell | Tax Withholding | 1,623 | $53K | 11/18/2023 | View on chart |
| ADNT | ▼ Sell | Tax Withholding | 2,170 | $71K | 11/17/2023 | View on chart |
| ADNT | ▲ Buy | Grant | 19,494 | — | 11/16/2023 | View on chart |
| ADNT | ▲ Buy | Grant | 46,766 | — | 11/16/2023 | View on chart |
| ADNT | ▼ Sell | Tax Withholding | 22,214 | $729K | 11/16/2023 | View on chart |
| ADNT | ▼ Sell | Tax Withholding | 2,444 | $97K | 11/19/2022 | View on chart |
| ADNT | ▼ Sell | Tax Withholding | 4,948 | $196K | 11/18/2022 | View on chart |
| ADNT | ▲ Buy | Grant | 13,838 | $0 | 11/17/2022 | View on chart |
| ADNT | ▲ Buy | Grant | 10,149 | $0 | 11/17/2022 | View on chart |
| ADNT | ▼ Sell | Tax Withholding | 4,821 | $186K | 11/17/2022 | View on chart |
| ADNT | ▼ Sell | Open Market | 1,200 | $44K | 11/9/2022 | View on chart |
| ADNT | ▼ Sell | Tax Withholding | 1,683 | $51K | 7/1/2022 | View on chart |
| ADNT | ▼ Sell | Tax Withholding | 220 | $7K | 5/8/2022 | View on chart |
| ADNT | ▼ Sell | Tax Withholding | 2,444 | $113K | 11/19/2021 | View on chart |
| ADNT | ▲ Buy | Grant | 9,275 | $0 | 11/18/2021 | View on chart |
| ADNT | ▲ Buy | Grant | 4,857 | $0 | 11/18/2021 | View on chart |
| ADNT | ▼ Sell | Tax Withholding | 5,613 | $263K | 11/18/2021 | View on chart |
| ADNT | ▼ Sell | Open Market | 3,100 | $137K | 11/11/2021 | View on chart |
| ADNT | ▼ Sell | Tax Withholding | 545 | $23K | 10/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
Adient Q4 Earnings Set for Nov. 4 as Analysts Trim Targets
Adient will report fourth-quarter and full-year fiscal 2026 results on November 4, 2026. Ahead of this announcement, Barclays and UBS both lowered their price targets to $22 and $23, respectively, while maintaining their ratings. Recent commentary also highlights strong backlog growth driven by onshoring initiatives and new customer wins.
Adient Q4 Earnings Set for Nov. 4 as Analysts Trim Targets. Adient will report fourth-quarter and full-year fiscal 2026 results on November 4, 2026. Ahead of this announcement, Barclays and UBS both lowered their price targets to $22 and $23, respectively, while maintaining their ratings. Recent commentary also highlights strong backlog growth driven by onshoring initiatives and new customer wins.